Glioma, pancreatic cancer, and intrahepatic cholangiocarcinoma have been reported to possess the SPP1-CD44 axis that is immunosuppressive and pro-tumor (74–76). This evidence concerns the gene CD44 and intrahepatic cholangiocarcinoma.